Treatment of Nonunion of Limb Fracture With Human Amniotic Epithelial Cells(hAECs)
- Conditions
- Nonunion Fracture
- Registration Number
- NCT03031509
- Lead Sponsor
- Shanghai East Hospital
- Brief Summary
The purpose of this study is to evaluate the efficacy and safety of human amniotic epithelial cells transplant in nonunion of limb fracture patients.
- Detailed Description
In this study, patients of nonunion after limb fracture will be treated with human amniotic epithelial cells. Clinical and radiological assessment is performed.
hAECs developing from the epiblast as early as 8 days after fertilization, recent data reported indicate that hAECs possess proper osteogenic differentiation potential and a localized modulatory influence on the early tissue remodeling process, making these cells a promising stem cell source for bone regeneration after fractures.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 36
- diagnosed with nonunion of limbs by x-ray and bone scan;
- compliance to treatment and long term follow-up;
- be able and willing to participate in the study;
- written informed consent before study.
- pregnant or breastfeeding;
- patients with malignancy, immunocompromised ( HIV AIDS, Diabetes mellitus, active Hepatitis), in a immunosuppressant therapy ( chemotherapy or steroids), OR health status, mental diseases, which will influence the study;
- patients undergoing any other treatment that are not related to this study;
- others considered not appropriate selected patients.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method time for bone union 6 months Bone union was evaluated at 6-month after surgery according to the following definition.Definition of bone union is when simple X-ray findings reveal that bone trabeculae or cortical bone exceeds the fracture site.
- Secondary Outcome Measures
Name Time Method limb functional score 1 year pain in fracture site 1 year
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Shanghai East Hospital
🇨🇳Shanghai, China
Shanghai East Hospital🇨🇳Shanghai, ChinaLIN LIContact86-021-61569006